Search Results

You are looking at 91 - 100 of 793 items for :

  • "screening" x
Clear All
Full access

Population Best Practices in Implementation and Use of Clinical Practice Guidelines AB2015-9. Longitudinal Evaluation of a Colorectal Cancer Screening Measurement Model Bryan Loy, MD MBA; William T. Brooks, BS; Michael Yang, MD, MS; Laura E

Full access

Christina Rybak and Michael J. Hall

hereditary nonpolyposis colorectal cancer. Previously, an understanding of the workup of individuals suspected of having LS could be left to those specializing in genetics. Recently, screening of all patients with newly diagnosed CRC for LS independent of

Full access

The February 2012 article by Goulart et al titled, “Lung Cancer Screening With Low-Dose Computed Tomography: Costs, National Expenditures, and Cost-Effectiveness,” (J Natl Compr Canc Netw 2012, doi: 10.6004/jnccn.2012.0023 ) was published with an

Full access

Kathleen N. Moore and Joan L. Walker

and pathologic study of koilocytotic atypia . Ann N Y Acad Sci 1956 ; 63 : 1245 – 1261 . 5 Clavel C Masure M Bory JP . Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932

Full access

Hanna K. Sanoff, YunKyung Chang, Joseph M. Stavas, Til Stürmer and Jennifer Lund

this article at JNCCN.org ). Laboratory parameters were not available, and therefore diagnosis codes for complications of cirrhosis were used to control for confounding liver disease. 24 HCC screening behavior was ascertained based on prediagnosis α

Full access

Deborah J. MacDonald, Kathleen R. Blazer and Jeffrey N. Weitzel

R apidly evolving genetic and genomic technologies for genetic cancer risk assessment (GCRA) are revolutionizing the approach to targeted therapy and cancer screening and prevention, heralding the era of personalized medicine. Although academic

Full access

Ruben Niesvizky and Ashraf Z. Badros

. Table 1 lists risk factors and related screening considerations for MM patients. 2 , 12 , 26 According to the IMWG, selection of candidates for thromboprophylaxis should be based on the baseline VTE risk associated with each therapy. 12 The IMWG

Full access

Kristine A. Donovan and Paul B. Jacobsen

2005 4 but designed to solicit more details about screening procedures. Survey items focused on the availability of mental health services, screening methods used to identify distressed patients, and the providers of services if a distressed patient

Full access

Robert A. Smith

Screening for Disease. Geneva, Switzerland : World Health Organization , 1968 . 2 Parkin DM . Global cancer statistics in the year 2000 . Lancet Oncol 2001 ; 2 : 533 – 543 . 3 American Cancer Society . American Cancer Society

Full access

Sowmya Boddhula, Satish Kumar Boddhula, Bishesh Shrestha, Kelly Morris and Rosana Gnanajothy

). HBV screening and appropriate use of prophylactic antiviral therapy is recommended to prevent reactivation. A software program named Beacon Oncology was integrated into Epic, which creates an automated alert for HBV screening before starting first dose